Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Your search was processed without automatic term mapping because it retrieved zero results.
Page 1
Epidermal growth factor receptor-targeted therapy with C225 and cisplatin in patients with head and neck cancer.
Clin Cancer Res. 2001 May;7(5):1204-13.
Clin Cancer Res. 2001.
PMID: 11350885
Clinical Trial.
Phase I study of anti--epidermal growth factor receptor antibody cetuximab in combination with radiation therapy in patients with advanced head and neck cancer.
Robert F, Ezekiel MP, Spencer SA, Meredith RF, Bonner JA, Khazaeli MB, Saleh MN, Carey D, LoBuglio AF, Wheeler RH, Cooper MR, Waksal HW.
Robert F, et al.
J Clin Oncol. 2001 Jul 1;19(13):3234-43. doi: 10.1200/JCO.2001.19.13.3234.
J Clin Oncol. 2001.
PMID: 11432891
Clinical Trial.
A standard dose escalation procedure was used; three patients entered onto the study at each dose level of cetuximab received conventional RT (70 Gy, 2 Gy/d), and the final three patients received hyperfractionated RT (76.8 Gy, 1.2 Gy bid). ...
A standard dose escalation procedure was used; three patients entered onto the study at each dose level of cetuximab received conventional R …
Item in Clipboard
Cite
Cite